Article
CAR T-Cell Therapy Transforms Myeloma Treatment, But Questions Remain
Rating:
0.0
Views:
66
Likes:
1
Library:
1
Investigational CAR T-cell therapy products have demonstrated unprecedented responses rates with seemingly durable remissions in patients with relapsed/refractory multiple myeloma, explained Luciano J. Costa, MD.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value